Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter Urinary Tract Infections. (CAUTION)
A Pilot Concealed Randomized Double-blinded Placebo-controlled Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter-associated Urinary Tract Infections in the Critically Ill
Urinary tract infection (UTI) is a common infection in patients in the intensive care unit (ICU) that increases length of stay but not mortality. It is not known whether antibiotic treatment will alter outcomes. Our previous studies have documented wide practice variations exist amongst doctors, including prescribing antibiotics to asymptomatic patients. Therefore, the merits of various ways to manage the infection require further studies to minimize the potential for over-prescribing of antibiotics, a practice that can increase the development of resistant bacteria.
The objective of this pilot study is to determine the feasibility of conducting a larger definitive study that will determine the effect of catheter change and/or systemic antibiotics as compared to no interventions on outcomes and resource utilization in ICU patients with UTI. Patients will be randomized to receive no treatment, antibiotics alone, urine catheter change alone, and both catheter change and antibiotics. Their clinical outcomes will be assessed.
Results from the pilot trial will provide information about whether it is feasible to conduct the larger definitive trial. Results of the definitive study will provide guidance to clinicians on how to manage a frequent clinical problem and optimize antibiotic usage.
調査の概要
研究の種類
段階
- フェーズ 3
連絡先と場所
研究場所
-
-
Ontario
-
Toronto、Ontario、カナダ、M5B1W8
- St. Michael's Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adult ICU patient (≥ 18 years old)
- Admitted to the ICU for ≥ 96 hours
- Indwelling urinary catheter in place for ≥ 48hours that was inserted during this hospital admission
- Urine culture positive (≥ 105 CFU/mL) for 1 or 2 organism (s) (e.g. bacteria or fungus)
- Have received antimicrobial therapy that would cover the isolated organism(s) in the index urine culture for < 24 hours (i.e. therapy that does NOT cover the isolated organism(s) in the index urine culture of any duration or antimicrobial that covers the index urine organism for < 24 hours are permitted)
Exclusion Criteria:
- Suspected or confirmed pyelonephritis, renal abscess, or concurrent bacteremia with the same organism(s) as those isolated in the index urine culture
- Anuria (< 50 mL/day)
- Imminent death within 48 hours or decision to withdraw supportive care by clinical team
- Neutropenia (< 500/mm3)
- Patient has an alternative infection and requires an antimicrobial that has a spectrum of activity which include all the organism(s) isolated from the index urine culture
- Mixed fungal/bacterial CAUTI (i.e. index urine culture contains both bacteria and fungus)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:階乗代入
- マスキング:4倍
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
介入なし:No catheter change no antimicrobial
Urinary catheter will not be changed and no antimicrobials will be prescribed
|
|
アクティブコンパレータ:Antimicrobial and catheter change
|
Appropriate antimicrobial based on urine culture results
Change urine catheter
|
アクティブコンパレータ:Catheter change and NO antimicrobial
|
Change urine catheter
|
アクティブコンパレータ:Antimicrobial and NO catheter change
|
Appropriate antimicrobial based on urine culture results
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Number of patients enrolled
時間枠:18 months
|
none enrolled
|
18 months
|
Protocol Adherence Rate
時間枠:18 months
|
18 months
|
二次結果の測定
結果測定 |
時間枠 |
---|---|
ICU free days at Day 30
時間枠:30 days
|
30 days
|
Microbiologic Outcome
時間枠:Day 7 and 14
|
Day 7 and 14
|
Developement of resistance
時間枠:14 days
|
14 days
|
協力者と研究者
スポンサー
協力者
捜査官
- 主任研究者:Jan Friedrich, DPhil, MD, MSc、Unity Health Toronto
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。